DRUG ENFORCEMENT ADMINISTRATION ISSUES PROPOSED RULE: SCHEDULES OF CONTROLLED SUBSTANCES: RESCHEDULING OF SUVOREXANT, LEMBOREXANT, AND DARIDOREXANT FROM SCHEDULE IV INTO SCHEDULE V

WASHINGTON, Aug. 11 -- Drug Enforcement Administration has issued a proposed rule called: Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V.

The proposed rule was published in the Federal Register on Aug. 11 by Heather Achbach, Federal Register Liaison Officer, Drug Enforcement Administration.

Summary: The Drug Enforcement Administration proposes to transfer suvorexant ([(7 R)-4-(5-chloro-1, 3-benzoxazol-2-yl)-7-methyl-1, 4-diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone), lemborexant ((1 R, 2 S)-2-[(2, 4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)- N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide), and daridorexant ([(2 S)-2-(5-chloro-4-meth...